Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-05, Stock:NVS, The news for the past five days is as follows:
2019-06-27: NEWS1: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS2: Dova Receives Approval for Doptelet in Europe, Stock Up.NEWS3: Dova Receives Approval for Doptelet in Europe, Stock Up.NEWS4: FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review.NEWS5: FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review.NEWS6: FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review.NEWS7: Dova Receives Approval for Doptelet in Europe, Stock Up.NEWS8: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS9: Is Allergan a Good Deal for AbbVie?.
2019-06-28: NEWS1: Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View.NEWS2: Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View.NEWS3: Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View.
2019-07-01: NEWS1: Roche's Tecentriq Gets CHMP Recommendation for Breast Cancer.NEWS2: Atara Reports Initial Data for Multiple Sclerosis Candidate.NEWS3: Atara Reports Initial Data for Multiple Sclerosis Candidate.NEWS4: Atara Reports Initial Data for Multiple Sclerosis Candidate.NEWS5: 3 Small-Cap Biotech Stocks That Soared Last Week.NEWS6: Miraca and Seventh Sense Biosystems, Inc. Announce Strategic Investment and Distribution Agreement.
2019-07-02: NEWS1: Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx.NEWS2: Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx.NEWS3: Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx.NEWS4: Alnylam Submits MAA in Europe for RNAi Therapeutic Givosiran.NEWS5: Alnylam Submits MAA in Europe for RNAi Therapeutic Givosiran.NEWS6: Alnylam Submits MAA in Europe for RNAi Therapeutic Givosiran.NEWS7: AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label.NEWS8: AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label.NEWS9: Market Morning: Swiss Bans Stocks from EU, Bitcoin Breaks Below $10K, USTR Wants More Tariffs.NEWS10: AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label.NEWS11: Roche's Tecentriq Gets CHMP Recommendation for Breast Cancer.NEWS12: Roche's Tecentriq Gets CHMP Recommendation for Breast Cancer.
2019-07-03: NEWS1: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS2: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS3: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS4: Pre-Market Most Active for Jul 3, 2019 :  SYMC, CGC, NVS, NIO, TSLA, TVIX, OMN, AMD, SAP, ZAYO, TQQQ, QQQ.NEWS5: Pre-Market Most Active for Jul 3, 2019 :  SYMC, CGC, NVS, NIO, TSLA, TVIX, OMN, AMD, SAP, ZAYO, TQQQ, QQQ.

Answer: Decrease